BioHarvest Sciences Inc.
BHST | NASDAQ
$1.51
-$0.11 (-6.79%)
At close: Sep 22, 2026, 4:00 PM ET
$1.51
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:46 PM ET
Market Data
Market Cap $28.07M
Enterprise Value $29.4M
Beta 1.36
Average Volume 47.44K
Shares Outstanding (Diluted) 22.67M
Shares Change YoY 30.81%
Institutional Ownership 7.51%
Exchange NASDAQ
ISIN CA09076J2074
Price Performance
Price Change 1M -21.7%
Price Change 3M -47.7%
Price Change 6M -62.8%
Price Change YTD -68.9%
Price Change 1Y -82.6%
Price Change 3Y -66.3%
Price Change 5Y -66.3%
1M CAGR (ann.) -36.7%
1Y CAGR (ann.) -81.4%
5Y CAGR (ann.) N/A
All-Time CAGR -44.4%
Valuation
PE Ratio -3.00
Forward PE 34.20
PEG Ratio -0.11
Forward PEG 0.08
PS Ratio 0.79
Forward PS 0.60
PB Ratio 1.42
P/FCF Ratio -2.56
P/Adj. FCF Ratio -2.53
P/OCF Ratio -4.26
EV/Sales 0.83
EV/EBIT -3.26
EV/EBITDA -4.03
EV/FCF -2.68
Earnings Yield -33.3%
FCF Yield -39.0%
Adj. FCF Yield -39.5%
Financial Health
Net Cash $528K
Total Debt $17.55M
Cash & Short-Term Investments $16.22M
Total Assets $44.57M
Current Ratio 2.24
Quick Ratio 1.75
Debt / Equity Ratio 0.89
Debt / EBITDA -2.41
Debt / FCF -1.60
OCF / Debt -0.50
Interest Coverage -1.21
Altman Z-Score -2.38
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 59.0%
Operating Profit Margin -18.0%
EBITDA Margin -20.6%
Net Profit Margin -31.2%
FCF Margin -30.9%
Adj. FCF Margin -31.3%
SBC / Revenue 0.4%
SBC Impact (per share) -1.4%
Returns
Return on Assets -24.8%
Return on Equity -58.3%
Return on Invested Capital -17.1%
Return on Capital Employed -19.4%
Return on Tangible Assets -24.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 58.7%
Revenue CAGR 5Y 102.5%
Revenue CAGR 10Y 40.6%
EPS CAGR 3Y 40.1%
EPS CAGR 5Y 6.4%
EPS CAGR 10Y 2.4%
FCF CAGR 3Y -9.5%
FCF CAGR 5Y -2.1%
FCF CAGR 10Y -23.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y 60.5%
Revenue Growth Next 3Y 44.7%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.16
EPS Growth Est (next Q) 14.3%
Revenue Est (next Q) $9.31M
Revenue Growth Est (next Q) 2.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $5
Price Target Upside 208.6%
Cash Flow
Operating Cash Flow $-8.71M
Free Cash Flow $-10.95M
Adj. Free Cash Flow $-11.1M
FCF Per Share -$0.48
OCF Per Share -$0.38
OCF/S Ratio -24.6%
Income Statement
Revenue $35.48M
Gross Profit $20.91M
Operating Income $-6.38M
EBITDA $-7.29M
Net Income $-11.07M
EPS (Diluted) -$0.54
Revenue / Employee $398.62K
Profit / Employee $-124.42K
Employees 89
Add to Watchlist
Select watchlists to add or remove BHST